LINC01355 suppresses breast cancer growth through FOXO3-mediated transcriptional repression of CCND1

Bolun Ai1, Xiangyi Kong1, Xiangyu Wang1

  • 1Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Cell Death & Disease
|June 28, 2019
PubMed

Insights

Long non-coding RNA LINC01355 acts as a tumor suppressor in breast cancer by inhibiting cell growth and progression. Its re-expression may offer a new therapeutic strategy against breast cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The 1p36 chromosomal locus contains known tumor suppressor genes.
  • Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in cancer.
  • The function of lncRNAs at the 1p36 locus in breast cancer remains largely unexplored.

Purpose of the Study:

  • To identify and characterize functional lncRNAs with tumor-suppressive activity in breast cancer.
  • To elucidate the molecular mechanism underlying the function of identified lncRNAs.
  • To evaluate the clinical relevance of these lncRNAs in breast cancer patients.

Main Methods:

  • Small interfering RNA (siRNA) screening to identify growth-inhibitory lncRNAs.
  • Overexpression and knockdown experiments in breast cancer cell lines.
  • Cell cycle analysis, proliferation, colony formation, and tumorigenesis assays.
  • Western blotting, qRT-PCR, and RNA immunoprecipitation (RIP) assays.
  • Analysis of clinical breast cancer specimens.

Main Results:

  • LINC01355 was identified as a downregulated lncRNA in breast cancer cells.
  • Overexpression of LINC01355 inhibited breast cancer cell proliferation, colony formation, and tumorigenesis.
  • LINC01355 induced G0/G1 cell cycle arrest by repressing CCND1 expression.
  • LINC01355 stabilized FOXO3 protein, enhancing FOXO3-mediated transcriptional repression of CCND1.
  • Downregulation of LINC01355 correlated with aggressive breast cancer features and poor prognosis.

Conclusions:

  • LINC01355 functions as a tumor suppressor in breast cancer.
  • The tumor-suppressive role of LINC01355 is mediated through the FOXO3/CCND1 pathway.
  • LINC01355 represents a potential therapeutic target for breast cancer treatment.

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K
Repressed Memory01:16

Repressed Memory

Repressed memories are a psychological phenomenon where memories of traumatic events are unconsciously blocked from a person's awareness. This process occurs as a defense mechanism, protecting the mind from the emotional impact of distressing or painful experiences. For example, a person who has experienced childhood trauma may grow up with no conscious recollection of the event. In such cases, the memories are thought to be buried deep within the subconscious, inaccessible to the conscious...
505
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.3K
Prokaryotic Transcriptional Activators and Repressors01:58

Prokaryotic Transcriptional Activators and Repressors

The organization of prokaryotic genes in their genome is notably different from that of eukaryotes. Prokaryotic genes are organized, such that the genes for proteins involved in the same biochemical process or function are located together in groups. This group of genes, along with their regulatory elements, are collectively known as an operon. The functional genes in an operon are transcribed together to give a single strand of mRNA known as polycistronic mRNA.
Transcription of prokaryotic...
25.2K
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
12.6K
Transcription01:10

Transcription

Overview
Transcription is the process of synthesizing RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in the proper synthesis of messenger RNA (mRNA). Regulation of transcription is responsible for the differentiation of all the different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds...
155.7K